International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 8, Issue 3 (May-June 2026) Submit your research before last 3 days of June to publish your research paper in the issue of May-June.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 8 Issue 3
May-June 2026

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Pharmaceutical Industry and Access to Medicines: In-Depth Analysis

Author(s) Ms. Princy Joseph
Country India
Abstract Millions of people receive affordable, high-quality generic medications from the Indian pharmaceutical industry, which is crucial to the global healthcare system. However, despite its achievements, the sector grapples with significant barriers to equitable access to medicines. This study explores the relationship between India’s pharmaceutical sector and accessibility to medicine, highlighting key factors behind the country’s emergence as a leading pharmaceutical hub. The analysis identifies economic constraints, patent regulations, regulatory hurdles, and disparities in healthcare infrastructure as major obstacles to widespread access to medicines. To overcome these issues, the study advocates a comprehensive strategy that includes effective price controls, reforms in intellectual property laws, simplification of regulatory processes, and increased investments in healthcare infrastructure. Additionally, promoting generic medicine adoption, strengthening the pharmaceutical supply chain, and community engagement are essential for improving access to medicines. By adopting a comprehensive and systemic perspective, India can ensure that the benefits of the pharmaceutical industry translate into improved healthcare outcomes for all. The findings underline the importance of collaboration among policymakers, healthcare professionals, and the pharmaceutical industry to enhance accessibility to essential medicines, ultimately contributing to a healthier and more robust society.
Keywords Pharmaceutical Industry, Healthcare Infrastructure, Access to Medicine, Indian Healthcare, Generic Medicines, Intellectual Property Rights.
Published In Volume 7, Issue 6, November-December 2025
Published On 2025-11-07
DOI https://doi.org/10.36948/ijfmr.2025.v07i06.59894
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 8 Isu 3Cover Page Vol 8 Isu 2Cover Page Vol 8 Isu 2

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9687-828-838 editor@ijfmr.com
Powered by Sky Research Publication and Journals